• Je něco špatně v tomto záznamu ?

Current knowledge of methicillin-resistant Staphylococcus aureus and community-associated methicillin-resistant Staphylococcus aureus

Ivanka Matouskova, Vladimir Janout

Jazyk angličtina Země Česko

Typ dokumentu přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc10009395

Background: Bacterial strains that are oxacillin and methicillin-resistant, historically termed methicillin-resistantStaphylococcus aureus (MRSA) are resistant to all ß-lactam agents, including cephalosporins and carbapenems. MRSAare pathogenic and have a number of virulence factors that enable them to result in disease. They are transmissibleand important causes of nosocomial infections worldwide. An MRSA outbreak can occur when one strain is transmittedto other patients or through close contacts of infected persons in the community. Hospital-associated MRSA(HA-MRSA) isolates are also frequent causes of healthcare-associated bloodstream and catheter-related infections.Community-associated MRSA (CA-MRSA) isolates are often only resistant to beta-lactam agents and erythromycinbut they are an emerging cause of community-associated infections, ecpecially skin and soft tissue infections (SSTI)and necrotizing pneumonia. Methods: Current possibilities for detecting MRSA strains in the laboratory are reviewed and discussed in thecontext of the recent literature.Results and Conclusion: The active surveillance and prevention of MRSA occurence and spreading in hospitals arediscussed in the context of recent literature.

Citace poskytuje Crossref.org

Bibliografie atd.

Lit.: 167

000      
00000naa 2200000 a 4500
001      
bmc10009395
003      
CZ-PrNML
005      
20111210162326.0
008      
100420s2008 xr e eng||
009      
AR
024    7_
$a 10.5507/bp.2008.030 $2 doi
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Matoušková, Ivanka $7 mzk2005312998
245    10
$a Current knowledge of methicillin-resistant Staphylococcus aureus and community-associated methicillin-resistant Staphylococcus aureus / $c Ivanka Matouskova, Vladimir Janout
314    __
$a Department of Preventive Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc
504    __
$a Lit.: 167
520    9_
$a Background: Bacterial strains that are oxacillin and methicillin-resistant, historically termed methicillin-resistantStaphylococcus aureus (MRSA) are resistant to all ß-lactam agents, including cephalosporins and carbapenems. MRSAare pathogenic and have a number of virulence factors that enable them to result in disease. They are transmissibleand important causes of nosocomial infections worldwide. An MRSA outbreak can occur when one strain is transmittedto other patients or through close contacts of infected persons in the community. Hospital-associated MRSA(HA-MRSA) isolates are also frequent causes of healthcare-associated bloodstream and catheter-related infections.Community-associated MRSA (CA-MRSA) isolates are often only resistant to beta-lactam agents and erythromycinbut they are an emerging cause of community-associated infections, ecpecially skin and soft tissue infections (SSTI)and necrotizing pneumonia. Methods: Current possibilities for detecting MRSA strains in the laboratory are reviewed and discussed in thecontext of the recent literature.Results and Conclusion: The active surveillance and prevention of MRSA occurence and spreading in hospitals arediscussed in the context of recent literature.
650    _2
$a methicilin rezistentní Staphylococcus aureus $x genetika $x imunologie $x účinky léků $7 D055624
650    _2
$a beta-laktamová rezistence $x genetika $x imunologie $x účinky léků $7 D018440
650    _2
$a rezistence k cefalosporinům $x genetika $x imunologie $x účinky léků $7 D018550
650    _2
$a karbapenemy $x škodlivé účinky $x terapeutické užití $7 D015780
650    _2
$a infekce spojené se zdravotní péčí $x etiologie $x genetika $x imunologie $7 D003428
650    _2
$a infekce získané v komunitě $x etiologie $x genetika $x imunologie $7 D017714
650    _2
$a kontrola infekčních nemocí $x metody $7 D003140
650    _2
$a antibakteriální látky $x aplikace a dávkování $x dějiny $x terapeutické užití $7 D000900
650    _2
$a polymerázová řetězová reakce $x metody $x využití $7 D016133
650    _2
$a bakteriologické techniky $x metody $x využití $7 D001431
650    _2
$a plošný screening $x metody $x využití $7 D008403
650    _2
$a primární prevence $x metody $7 D011322
650    _2
$a medicína založená na důkazech $x statistika a číselné údaje $x trendy $7 D019317
650    _2
$a financování organizované $7 D005381
650    _2
$a lidé $7 D006801
655    _2
$a přehledy $7 D016454
700    1_
$a Janout, Vladimír, $d 1939- $7 jn20010524003
773    0_
$w MED00012606 $t Biomedical papers $g Roč. 152, č. 2 (2008), s. 191-202 $x 1213-8118
856    41
$u http://biomed.papers.upol.cz/pdfs/bio/2008/02/02.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 1502 $c 958 $y 8
990    __
$a 20100419115931 $b ABA008
991    __
$a 20100511090825 $b ABA008
999    __
$a ok $b bmc $g 723270 $s 586385
BAS    __
$a 3
BMC    __
$a 2008 $b 152 $c 2 $d 191-202 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x MED00012606
LZP    __
$a 2010-22/dkal

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...